Bausch Health’s Salix Says Cirrhosis Care Pathway Pilot Raised Hepatic Encephalopathy Treatment Rates From 60.2% To 64.9%
Share
Why It Matters
Bausch Health's Salix division tested a new way to care for liver disease patients. More patients got treated for a serious liver problem, which suggests the approach might work.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.